Use with caution if you have a history of pancreatitis seek immediate medical advice if you develop severe abdominal pain
As of mid-2024, a full 6% of US adults are actively taking GLP-1 agonists , but the huge potential addressable market for these drugs, combined with an ongoing shortage, means that these medications have plenty of additional potential running room
When a patient has exhausted semaglutide's dose ceiling and weight loss has stalled, physicians often consider tirzepatide to engage the additional receptor pathway
The persistence of constipation distinguishes it from most other GLP1 side effects
[1] CYP2A6 polymorphism is far less common (only 1% of Caucasians and 20% of Asians possess known variants), meaning there's greater than 99% probability of having at least one normal enzyme pathway handling paraxanthine clearance
Identification of P4HA1 as a prognostic biomarker for high-grade gliomas